Tibshirani RJ - Search Results

1

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.

Lossos C, Bayraktar S, Weinzierl E, Younes SF, Hosein PJ, Tibshirani RJ, Sutton Posthumus J, DeAngelis LM, Raizer J, Schiff D, Abrey L, Natkunam Y, Lossos IS. Lossos C, et al. Among authors: tibshirani rj. Br J Haematol. 2014 Jun;165(5):640-8. doi: 10.1111/bjh.12801. Epub 2014 Feb 26. Br J Haematol. 2014. PMID: 24571259 Free PMC article. Review.

2

Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas.

Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC, Levy R. Lossos IS, et al. Blood. 2000 Mar 1;95(5):1797-803. Blood. 2000. PMID: 10688840 Free article.

3

The inference of antigen selection on Ig genes.

Lossos IS, Tibshirani R, Narasimhan B, Levy R. Lossos IS, et al. J Immunol. 2000 Nov 1;165(9):5122-6. doi: 10.4049/jimmunol.165.9.5122. J Immunol. 2000. PMID: 11046043

4

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R. Lossos IS, et al. Blood. 2001 Aug 15;98(4):945-51. doi: 10.1182/blood.v98.4.945. Blood. 2001. PMID: 11493437 Free article.

5

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, Levy R. Lossos IS, et al. Blood. 2003 Jan 15;101(2):433-40. doi: 10.1182/blood-2002-06-1931. Blood. 2003. PMID: 12509382 Free article.

6

Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Fan Z, et al. Am J Surg Pathol. 2003 Oct;27(10):1346-56. doi: 10.1097/00000478-200310000-00007. Am J Surg Pathol. 2003. PMID: 14508396

7

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R. Lossos IS, et al. N Engl J Med. 2004 Apr 29;350(18):1828-37. doi: 10.1056/NEJMoa032520. N Engl J Med. 2004. PMID: 15115829 Free article.

8

Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.

Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE Jr, Lossos IS, Natkunam Y. Gratzinger D, et al. Among authors: tibshirani rj. Lab Invest. 2008 Jan;88(1):38-47. doi: 10.1038/labinvest.3700697. Epub 2007 Nov 12. Lab Invest. 2008. PMID: 17998899 Free article.

9

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.

Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Levy R, Gascoyne RD, Lossos IS. Natkunam Y, et al. J Clin Oncol. 2008 Jan 20;26(3):447-54. doi: 10.1200/JCO.2007.13.0690. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086797

10

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

Malumbres R, Chen J, Tibshirani R, Johnson NA, Sehn LH, Natkunam Y, Briones J, Advani R, Connors JM, Byrne GE, Levy R, Gascoyne RD, Lossos IS. Malumbres R, et al. Blood. 2008 Jun 15;111(12):5509-14. doi: 10.1182/blood-2008-02-136374. Epub 2008 Apr 29. Blood. 2008. PMID: 18445689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page